FDA inspection
Medefil Incorporated: FDA inspection ending Feb 2, 2024
FDA inspection 1230282 · Glendale Heights, IL
Key facts
| Inspection ID | 1230282 |
|---|---|
| Firm | Medefil Incorporated |
| FEI number | 3001677091 |
| Address | 250 Windy Point Dr |
| City | Glendale Heights |
| State | IL |
| ZIP | 60139-3805 |
| Fiscal year | 2024 |
| Inspection end date | Feb 2, 2024 |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data